Today, I will be looking at two great companies with significant cash flows to invest in.

Pfizer VS Moderna Third Quarter Earnings And Revenue

Valneva (NASDAQ: VALN) has had a good run this week. It soared 49% at the beginning of trading day Monday and has continued its positive ride.

Why Many parents are concerned about the effect of the coronavirus pandemic on their children.

Compared to its peers like Johnson and Johnson, and Merck, who are also vaccine manufacturers, Pfizer is a better bet and gives higher expected returns.

This week I take a look at two stalwarts in the pharmaceutical industry, and the effect they have had on investors in the race for a COVID-19 vaccine.

AstraZeneca will sell its vaccine to governments at significantly lower prices as compared to Pfizer and Moderna.

The company has selected Texas, New Mexico, Tennessee, and Rhode Island for the pilot program

Pfizer shares fell nearly 3 percent in the pre-market trading Monday following Moderna’s announcement.

Industries like entertainment, travel and hospitality, airlines, cruise ships, and casinos, were just a few of the sectors that reacted positively to the news.